3 results match your criteria: "University of South California Keck School of Medicine[Affiliation]"
Pathophysiological characteristics and therapeutic approaches for pulmonary injury and cardiovascular complications of coronavirus disease 2019.
Cardiovasc Pathol
June 2020
Department of Internal Medicine, McGovern School of Medicine, University of Texas Health Science Center at Houston, Houston, TX, USA; Division of Pulmonary, Critical and Sleep Medicine, University of South California Keck School of Medicine, Los Angeles, CA, USA.
Article Synopsis
- COVID-19, caused by the SARS-CoV-2 virus, rapidly became a global health crisis, infecting millions and primarily affecting the respiratory system before spreading to other organs.
- The virus leads to inflammation, cell death, and various complications, notably in the cardiovascular system, due to the role of ACE2 as a receptor for the virus.
- This review discusses recent research on the clinical and laboratory findings related to COVID-19, focusing on its pulmonary and cardiovascular impacts and potential treatment strategies.
Acquired reactive perforating collagenosis associated with papillary thyroid carcinoma: a paraneoplastic phenomenon?
Clin Exp Dermatol
March 2010
Department of Dermatology, University of South California-Keck School of Medicine, Los Angeles, CA 90033, USA.
Acquired reactive perforating collagenosis (ARPC) is an uncommon dermatosis characterized by transepidermal elimination of altered collagen. It is commonly seen in patients with diabetes mellitus and/or chronic renal insufficiency. Rarely, it has been reported in association with malignancy and other conditions.
View Article and Find Full Text PDFEffect of oral versus transdermal steroidal contraceptives on androgenic markers.
Am J Obstet Gynecol
June 2005
Division of Reproductive Endocrinology and Infertility, Department of Obstetrics and Gynecology, University of South California Keck School of Medicine, Los Angeles, USA.
Objective: The purpose of this study was to compare biochemical androgen profiles in women treated with the contraceptive patch versus an oral contraceptive (OC).
Study Design: Twenty-four healthy women were randomly assigned to receive 3 cycles of either the contraceptive patch (ethinyl estradiol [EE] 20 microg/d and norelgestromin 150 microg/d) or OC (EE 35 mug and norgestimate 250 microg). Blood samples were taken at baseline and end of treatment.